HOME >> BIOLOGY >> NEWS
3-D Structure of Human Tumor-Suppressor Protein Produced

COLUMBUS, Ohio -- Researchers here have determined the three-dimensional structure of the protein produced by one of the most important human tumor-suppressor genes.

The gene is the p16 tumor-suppressor gene. The protein produced by this gene, the p16 protein, normally prevents cells from dividing when they shouldn’t.

When this protein is missing or inactivated due to mutations in the p16 tumor-suppressor gene, cancer can occur. In fact, damage to the p16 protein is a factor in more than 70 different types of cancer.

The researchers have also produced computer-generated pictures of the protein.

“This was a major achievement because of the importance of this protein in cancer and because of the difficulty of the project,” said Ming-Daw Tsai, the researcher at Ohio State University’s Comprehensive Cancer Center who led the study.

“If we can develop a drug that mimics p16, that would be a potentially good approach for the treatment of cancer, which is the ultimate goal of work like this.

“Determining the structure of the protein is the first major step in developing such a drug,” said Tsai, a professor of chemistry and of biochemistry.

The study, conducted by Tsai and a team of Ohio State researchers, was published in a February issue of the journal Molecular Cell. They used nuclear magnetic resonance (NMR) spectroscopy to measure the location of the atoms within the protein and their distances from one another. This information was then fed into a computer to determine the molecule’s structure.

NMR spectroscopy uses a powerful magnetic field to make molecular measurements. The method enables the researchers to study the structure of the p16 protein in a water solution, which more closely represents the molecule’s structure as it would exist inside the cell.

This, in turn, will make it easier through further research to determine the protein’
'"/>

Contact: Ming-Daw Tsai
Tsai.7@osu.edu
(614) 292-3080
Ohio State University
2-Mar-1998


Page: 1 2

Related biology news :

1. Structure solved at Scripps shows how one human protein reduces potency of chemotherapy
2. Structure solved by Scripps scientists shows one way that body controls gene expression
3. Structure of a Nobel-prize winning molecule: Aquaporin
4. Structure of HIV-neutralizing antibody solved
5. Structure of key breast cancer receptor determined
6. Structure of cog at the hub of metabolism reveals anti-ageing function
7. Structure of pain-modulating enzyme described by scientists at the Scripps Research Institute
8. Structure reveals details of cells cargo-carriers
9. Structure of key receptor unlocked; Related proteins will fall like dominoes
10. New Science Press launches Proteins: From Sequence to Structure
11. Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/10/2016)... India , March 10, 2016 ... a new market research report "Identity and Access Management ... & Audit, Compliance, and Governance), by Organization Size, by ... to 2020", published by MarketsandMarkets, The market is estimated ... USD 12.78 Billion by 2020, at a Compound Annual ...
(Date:3/9/2016)... Nigeria . Recently, ... 23,000 public service employees either did not exist with ... unlawfully.    --> Nigeria . ... than 23,000 public service employees either did not exist ... salary unlawfully.    --> DERMALOG, the biometrics ...
(Date:3/3/2016)... 3, 2016  FlexTech, a SEMI Strategic Association Partner, ... Research & Development, Leadership in Education, and, in a ... 9 th year of the FLEXI Awards and ... individuals from past years . Judging was done ... set of criteria, by a panel of non-affiliated, independent, ...
Breaking Biology News(10 mins):
(Date:5/4/2016)... ... May 05, 2016 , ... CereScan, ... the National Stroke Association during National Stroke Awareness Month in May. An ... pages throughout the month. CereScan will donate $1 up to a maximum ...
(Date:5/4/2016)... N.J. , May 4, 2016  Bayer ... its oncology compound Stivarga ® (regorafenib) tablets ... carcinoma (HCC) has met its primary endpoint of ... study, called RESORCE, evaluated the efficacy and safety ... has progressed after treatment with sorafenib. The safety ...
(Date:5/4/2016)... ... May 04, 2016 , ... PBI-Gordon Corporation is pleased to announce ... , Doug began his career at PBI-Gordon in February 1988, after finishing his masters ... of roles, ranging from customer service to national product manager, to helping develop, name ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... enterprise talent development, skill-building and compliance training platform on mobile devices, today ... course: Overview of Regulatory Requirements for Medical Devices. The course is essential for ...
Breaking Biology Technology:
Cached News: